The Functional and Imaging Implications of Left Bundle Branch Pacing in Ischemic Cardiomyopathy
Fulvio Cacciapuoti1, Ciro Mauro1, Ilaria Caso2
1Division of Cardiology, "A. Cardarelli" Hospital, 80131 Naples, Italy.
Insights
Bundle branch pacing effectively treats heart failure with reduced ejection fraction by restoring synchronized heart contractions. This advanced therapy improves cardiac function and patient outcomes, offering an alternative to traditional resynchronization therapy.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Research
Background:
- Ischemic cardiomyopathy causes heart failure with reduced ejection fraction, worsened by electrical conduction delays and uncoordinated contractions.
- Conventional cardiac resynchronization therapy has limitations, including a high non-responder rate and potential worsening of dyssynchrony with right ventricular pacing.
Purpose of the Study:
- To review the impact of left bundle branch block-induced dyssynchrony on cardiac function.
- To evaluate the role of advanced imaging in assessing ventricular function and patient selection for pacing therapies.
- To examine the clinical outcomes and benefits of bundle branch pacing in heart failure patients.
Main Methods:
- Review of literature on left bundle branch block mechanics, hemodynamics, and imaging techniques for dyssynchrony.
- Analysis of clinical outcomes comparing bundle branch pacing with conventional resynchronization therapy.
- Exploration of the physiological effects of bundle branch pacing on cardiac function, stress hormones, and calcium handling.
Main Results:
- Conduction delays significantly impair cardiac function, increase myocardial stress, and worsen clinical outcomes in heart failure.
- Advanced imaging is crucial for identifying heart failure patients likely to benefit from conduction system pacing.
- Bundle branch pacing restores electrical coordination, enhancing ventricular function, reducing hospitalizations, and promoting reverse remodeling, with outcomes comparable or superior to traditional CRT.
Conclusions:
- Bundle branch pacing is a significant advancement in managing heart failure with reduced ejection fraction by improving cardiac synchrony and function.
- Careful patient selection using advanced imaging is critical for optimizing the benefits of bundle branch pacing.
- Further research is needed to refine implantation techniques and confirm long-term efficacy through large clinical trials.
Abstract:
Heart failure with reduced ejection fraction due to ischemic cardiomyopathy remains a significant clinical challenge. Electrical conduction delays exacerbate symptoms by causing uncoordinated contractions, reducing pumping efficiency, and increasing mortality. Right ventricular pacing further worsens dyssynchrony, while resynchronization therapy improves outcomes but has a high non-responder rate. Given these limitations, bundle branch pacing engages the heart's conduction system, restoring synchronized contraction and enhancing cardiac function. This review examines the impact of left-bundle-branch-block-induced dyssynchrony, the role of advanced imaging in assessing ventricular function, and the clinical outcomes of bundle branch pacing in heart failure patients. Specifically, we explore the mechanical and hemodynamic effects of left bundle branch block, imaging techniques for dyssynchrony evaluation, and the comparative benefits of bundle branch pacing versus resynchronization therapy. Conduction delays impair function, increase myocardial stress, and worsen clinical outcomes. Advanced imaging plays a critical role in patient selection, identifying those most likely to benefit from conduction system pacing. By restoring electrical coordination, bundle branch pacing enhances ventricular function, reduces hospitalizations, and promotes reverse remodeling. It offers similar or superior benefits to conventional resynchronization therapy, regulates stress hormones, reduces oxidative damage, and improves calcium handling. Bundle branch pacing represents a significant advancement in heart failure management, but careful patient selection remains crucial. Future research should focus on optimizing implantation techniques and validating long-term benefits through large-scale clinical trials.
